期刊文献+

前列腺癌组织GRP78和GRIM-1表达及其相关性分析 被引量:2

Expression and correlation between GRP78 and GRIM-1 in prostate cancer tissues
原文传递
导出
摘要 目的:探讨前列腺癌组织葡萄糖调节蛋白78(GRP78)和细胞凋亡相关基因-1(GRIM-1)表达及其与预后的关系。方法:采用免疫组织化学染色检测80例前列腺癌和50例良性前列腺增生组织GRP78、GRIM-1表达,比较GRP78、GRIM-1与前列腺癌患者临床资料的关系;Kaplan-Meier检验分析不同GRP78、GRIM-1表达与前列腺癌患者总体生存率的关系,Cox比例风险模型分析影响患者预后的因素。结果:前列腺癌组GRIM-1蛋白阳性率(90.0%,45/50)明显低于前列腺增生组(67.5%,54/80)(χ2=8.578,P=0.003);前列腺癌组GRP78蛋白阳性率(95.0%,76/80)明显高于前列腺增生组(76.0%,38/50)(χ2=10.292,P=0.001)。Gleason 2~7分组GRIM-1蛋白阳性率(82.4%,28/34)明显高于Gleason 8~10分组(56.5%,26/46);Gleason 2~7分组GRP78蛋白阳性率(88.2%,30/34)明显低于Gleason 8~10分组(100.0%,46/46),差异均具有统计学意义(P<0.05)。前列腺癌组织GRIM-1和GRP78表达呈负相关(r=-0.571,P<0.001);GRIM-1高表达组总体生存率明显高于低表达组;GRP78高表达组总体生存率明显低于低表达组,差异具有统计学意义(P<0.05)。多因素分析显示Gleason评分、TNM分期、病理分级、淋巴结转移、GRIM-1和GRP78蛋白表达是影响前列腺癌患者预后的独立因素(均P<0.05)。结论:前列腺癌组织中GRIM-1、GRP78异常表达;GRIM-1低表达和GRP78高表达与前列腺癌患者不良预后有关。 Objective:To explore the expression of glucose-regulated protein 78(GRP78)and gene associated with retinoid and interferon-induced mortality 1(GRIM-1)in prostate cancer tissues and its clinical value for prognositic.Methods:The expression of GRP78 and GRIM-1 in eighty prostate cancer tissues and fifty benign prostatic hyperplasia tissues were performed with immunohistochemical staining,the relationship between GRP78,GRIM-1 and prostate cancer patients clinical data were compared,the over-all survival of patients were analyzed by Kaplan-Meier method,the risk factors influencing the prognosis of prostate cancer patients were analyzed by Cox proportional hazards model.Results:The positive rate of GRIM-1 protein in the prostate cancer group(90.0%,45/50)was significantly lower than that in the benign prostatic hyperplasia group(67.5%,54/80)(χ2= 8.578,P = 0.003).The positive rate of GRP78 protein in the prostate cancer group(95.0%,76/80)was significantly higher than that in the benign prostatic hyperplasia group(76.0%,38/50)(χ2= 10.292,P = 0.001).The positive rate of GRIM-1 protein in the 2 ~ 7 score group(82.4%,28/34)was significantly higher than in that in the 8 ~ 10 score group(56.5%,26/46),while GRP78 positive rate in the 2 ~ 7 score group(88.2%,30/34)was significantly higher than in the 8 ~ 10 score group(100.0%,46/46),the difference was statistically significant(P 〈 0.05).There was a negative correlation between GRIM-1 and GRP78 in the prostate cancer tissues(r =-0.571,P 〈 0.001).The over-all survival in the GRIM-1 higher expression group was markedly higher than that in the lower expression group,and the over-all survival in the higher GRP78 expression group was markedly lower than that in the lower expression group,the difference was statistically significant(P 〈 0.05).Multivariate analysis showed that Gleason score,TNM stage,pathological grade,lymph node metastasis,GRP78 and GRIM-1 expression were independent risk factors for the poor prognostic of prostate cancer(all P 〈 0.05).Conclusion:Aberrant expression of GRP78 and GRIM-1 in prostate cancer tissues,the up-regulated of GRP78 and down-regulated of GRIM-1 are risk factors for the poor prognostic of prostate cancer.
作者 吴少芳 WU Shao-fang(Operation room, Tianmen First People's Hospital, Tianmen, Hubei, 431700, China)
出处 《现代医学》 2018年第2期162-167,共6页 Modern Medical Journal
关键词 前列腺癌 良性前列腺增生 葡萄糖调节蛋白78 细胞凋亡相关基因-1 Prostate cancer Benign prostatic hyperplasia Glucose-regulated protein 78 Gene associated with retinoid and interferon-induced mortality 1
  • 相关文献

参考文献6

二级参考文献73

  • 1叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 2龚龙波,罗学来,刘双又,陶德定,龚建平,胡俊波.GRIM-19及其靶基因产物STAT3与结直肠癌恶性程度的关系[J].癌症,2007,26(7):683-687. 被引量:43
  • 3Mearini E, Cottini E, Cochetti G, et al. Biomarkers of prostate cancer[J]. Minerva Urol Nefrol,2010,62(2) :163-178.
  • 4Aus G, Abbou CC, Bolla M, et al. EAU guidelines on prostate cancer[J]. Eur Urol, 2005,48(4) :546-551.
  • 5Amy S. GRP78 induction in cancer., therapeutic and prognostic implications[J]. Cancer Res, 2007,67(8) :3496-3499.
  • 6Madureira PA, Hill R, Miller VA, et al. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis[J]. Oncotarget, 2011,2(12) : 1075-1093.
  • 7Navarro D, Luzardo OP, Fernandez L, et al. Transition to androgen-independence in prostate cancer [J]. J Steroid Biochem Mol Biol, 2002,81(3):191-201.
  • 8Wang P, Chintagari NR, Gou D, et al. Physical and functional interactions of SNAP-23 with annexin A2[J]. Am J Respir Cell Mol Biol, 2007,37(4):467-476.
  • 9Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate [J]. Cancer Cell, 2006,10(3) :241-252.
  • 10Takano S, Togawa A, Yoshitomi H, et al. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy [J]. Ann Surg Oncol, 2008,15(11) :3157-3168.

共引文献280

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部